What Happened?
Newark, NJ-based Rafael Holdings Appointed Gus Kodersha as Chief Technical Operations Officer
About the Company
Rafael Holdings is focused on the development of novel cancer therapies. The company is a significant investor in two clinical stage oncology companies, Rafael Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd. Through its wholly owned Barer Institute subsidiary, the company is developing a pipeline of compounds focused on the regulation of cancer metabolism.
About the Person
Gus Kodersha is Chief Technical Operations Officer at Rafael Holdings. Previously, Gus held various senior IT leadership roles in the industry.
Info Source
News
Short Profile